trastuzumab
astrazeneca,daiichi sankyo
['trastuzumab']
the #oncoalerttoptweet day 3 #asco22 tweet #precisionmedicine happening at #asco22 -targeting her2 positive biliary tract #cancer using trastuzumab-deructecan 300+ pts screened orr 30% in her2+pts interesting pfs/os signal best 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??